NE therefore represents a promising target for the treatment of UC patients.

Background: Sustaining clinical remission is an important treatment goal in moderate-to-severe UC.

We used serum metabolomics to develop diagnostic and assessment methods for UC.

But this debate misses the underlying policy choices that are affecting UC.

UC showed no changes except a temporary increase in employment at 6-months.